Daouda sissoko
Daouda sissoko
Infectious & Emerging Diseases, Epidemiology
Dirección de correo verificada de - Página principal
Citado por
Citado por
A major epidemic of chikungunya virus infection on Reunion Island, France, 2005-2006.
P Renault, JL Solet, D Sissoko, E Balleydier, S Larrieu, L Filleul, ...
The American journal of tropical medicine and hygiene 77 (4), 727-731, 2007
Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005–2006 outbreak on Reunion
A Economopoulou, M Dominguez, B Helynck, D Sissoko, O Wichmann, ...
Epidemiology & Infection 137 (4), 534-541, 2009
Experimental treatment with favipiravir for Ebola virus disease (the JIKI Trial): a historically controlled, single-arm proof-of-concept trial in Guinea
D Sissoko, C Laouenan, E Folkesson, AB M’lebing, AH Beavogui, S Baize, ...
PLoS medicine 13 (3), e1001967, 2016
A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection
The New England Journal of Medicine 375 (15), 1448–1456, 2016
Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period
D Sissoko, D Malvy, K Ezzedine, P Renault, F Moscetti, M Ledrans, ...
PLoS neglected tropical diseases 3 (3), e389, 2009
Resurgence of Ebola virus disease in Guinea linked to a survivor with virus persistence in seminal fluid for more than 500 days
B Diallo, D Sissoko, NJ Loman, HA Bah, H Bah, MC Worrell, LS Conde, ...
Clinical infectious diseases 63 (10), 1353-1356, 2016
Seroprevalence and risk factors of chikungunya virus infection in Mayotte, Indian Ocean, 2005-2006: a population-based survey
D Sissoko, A Moendandze, D Malvy, C Giry, K Ezzedine, JL Solet, ...
PloS one 3 (8), e3066, 2008
Chikungunya virus–associated encephalitis: a cohort study on La Réunion Island, 2005–2009
P Gérardin, T Couderc, M Bintner, P Tournebize, M Renouil, J Lémant, ...
Neurology 86 (1), 94-102, 2016
Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted
THT Nguyen, J Guedj, X Anglaret, C Laouénan, V Madelain, AM Taburet, ...
PLoS neglected tropical diseases 11 (2), e0005389, 2017
Rift valley fever, Mayotte, 2007–2008
D Sissoko, C Giry, P Gabrie, A Tarantola, F Pettinelli, L Collet, ...
Emerging Infectious Diseases 15 (4), 568-570, 0
Transcriptomic signatures differentiate survival from fatal outcomes in humans infected with Ebola virus
X Liu, E Speranza, C Muñoz-Fontela, S Haldenby, NY Rickett, ...
Genome biology 18, 1-17, 2017
Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study
D Sissoko, S Duraffour, R Kerber, JS Kolie, AH Beavogui, AM Camara, ...
The Lancet Global Health 5 (1), e80-e88, 2017
Chikungunya outbreak in Reunion: epidemiology and surveillance, 2005 to early January 2006
C Paquet, I Quatresous, JL Solet, D Sissoko, P Renault, V Pierre, ...
Weekly releases (1997–2007) 11 (5), 2891, 2006
Factors associated with persistence of arthralgia among Chikungunya virus-infected travellers: report of 42 French cases
S Larrieu, N Pouderoux, T Pistone, L Filleul, MC Receveur, D Sissoko, ...
Journal of Clinical Virology 47 (1), 85-88, 2010
Ebola virus persistence in breast milk after no reported illness: a likely source of virus transmission from mother to child
D Sissoko, M Keïta, B Diallo, N Aliabadi, DL Fitter, BA Dahl, J Akoi Bore, ...
Clinical Infectious Diseases 64 (4), 513-516, 2017
Clinical efficacy of antiretroviral combination therapy based on protease inhibitors or non-nucleoside analogue reverse transcriptase inhibitors: indirect comparison of …
Y Yazdanpanah, D Sissoko, M Egger, Y Mouton, M Zwahlen, G Chêne
bmj 328 (7434), 249, 2004
Outbreak of Chikungunya fever in Mayotte, Comoros archipelago, 2005–2006
D Sissoko, D Malvy, C Giry, G Delmas, C Paquet, P Gabrie, F Pettinelli, ...
Transactions of the Royal Society of Tropical Medicine and Hygiene 102 (8 …, 2008
Field evaluation of clinical features during chikungunya outbreak in Mayotte, 2005–2006
D Sissoko, K Ezzedine, A Moendandzé, C Giry, P Renault, D Malvy
Tropical Medicine & International Health 15 (5), 600-607, 2010
Laboratory findings, compassionate use of favipiravir, and outcome in patients with Ebola virus disease, Guinea, 2015—a retrospective observational study
R Kerber, E Lorenz, S Duraffour, D Sissoko, M Rudolf, A Jaeger, SD Cisse, ...
The Journal of infectious diseases 220 (2), 195-202, 2019
Incidence rate and risk factors for loss to follow‐up in a French clinical cohort of HIV‐infected patients from January 1985 to January 1998
B Lebouche, Y Yazdanpanah, Y Gerard, D Sissoko, F Ajana, I Alcaraz, ...
HIV medicine 7 (3), 140-145, 2006
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20